Is Elevance Health, Inc. (ELV) Undervalued?
Based on the current stock price of $349.88 and a P/E ratio of 14.26,Elevance Health, Inc. has a PEG ratio of .
The Short Answer:
Most analysts consider a PEG ratio below 1.0 to be undervalued. With a ratio of , ELV appears to be fairly valued relative to its growth rate of -9.24%.
Based on a PEG ratio of 0.00.
Compare ELV vs Competitors
Use the calculator below to see how ELV stacks up against other stocks in the same industry.
How we analyzed ELV
We calculated the PEG (Price/Earnings-to-Growth) ratio by taking the Price-to-Earnings Ratio of 14.26and dividing it by the annual growth rate of -9.24%.
PEG = 14.26 (P/E) ÷ -9.24 (Growth) =
Frequently Asked Questions about ELV
What is the current PEG Ratio for Elevance Health, Inc. (ELV)?+
The current PEG Ratio for Elevance Health, Inc. is N/A. A PEG ratio below 1.0 generally suggests the stock may be undervalued relative to its growth.
Is ELV stock undervalued right now?+
Based on the PEG ratio of N/A, Elevance Health, Inc. appears to be fairly valued. Investors typically look for a PEG ratio below 1.0 to find undervalued growth stocks.
What is the PEGY Ratio for ELV?+
The PEGY ratio for Elevance Health, Inc. is N/A. This metric accounts for dividend yield (1.95%), providing a more complete valuation picture.